China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province

... TAIAN CITY Shandong China June 30 /Xinhua-PRNewswire-FirstCall/...The new plasma collection station will be located in the CentralizedI... Since we received approval to relocate Fang Cheng earlier this year...About China Biologic Products Inc. ...

TAIAN CITY, Shandong, China, June 30 /Xinhua-PRNewswire-FirstCall/ --
China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the
Company"), one of the leading plasma-based pharmaceutical companies in the
People's Republic of China ("PRC"), today announced that the Company
received the approval from the Guangxi Province Bureau of Health, to set up
a new plasma collection station in Pu Bei County, Guangxi Province.

The new plasma collection station will be located in the Centralized
Industry Zone of Pu Bei County and when it becomes operational, it will
replace CBP's existing Fang Cheng Plasma Collection Station ("Fang Cheng").
The Company's management decided to relocate the Fang Cheng Plasma
Collection Station to a more strategic location to increase collection
volumes. During the construction period, the existing Fang Cheng Plasma
Station will still continue with its normal operations. With the approval
of the new location, the Company hopes to expand its coverage area to
secure higher collection volumes in the future.

"Since we received approval to relocate Fang Cheng earlier this year,
we inspected several relocation sites and settled on Pu Bei County as the
best choice," said Mr. Chao Ming Zhao, the Company's CEO. "We are confident
that the new plasma collection station will help to greatly expand our
plasma supply once it is established."

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang
Biological Products Co. Ltd., China Biologic Products, Inc. (the
"Company"), is principally engaged in the research, development, production
and manufacturing and sale of plasma-based biopharmaceutical products to
hospitals and other health care facilities in China. The Company's human
albumin products are mainly used to increase blood volume and its
immunoglobulin products are used for the treatment and prevention of
diseases.

(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020). (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...

(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...

... (Ferrari), is considered one of the most serious ... beetle are difficult to combat; most of the insect,s ... and contact difficult. Female beetles bore holes into developing ... and create ,galleries, where they remain and deposit their ...